Weight Watchers CEO: what the GLP-1 Super Bowl ads are missing | Fortune
Briefly

Weight Watchers CEO: what the GLP-1 Super Bowl ads are missing | Fortune
"It was, in many ways, a cultural milestone. GLP-1 medications represent one of the most significant advances in weight management in generations, fundamentally reshaping what is possible for people living with overweight or obesity. They help regulate appetite and improve metabolic health, aiding millions in achieving meaningful weight loss. As they become more accessible and accepted, the demand for GLP-1s will only continue to grow."
"Weight Watchers has embraced the incredible potential of GLP-1s by building a nationwide team of clinicians who prescribe both the oral and injectable treatments through our Med+ program. But six decades of leadership in this industry has taught us that lasting weight health doesn't come from a single intervention. It is built over time-through daily choices, consistent support, and the work that goes into sustaining progress long after initial motivation may fade."
GLP-1 medications have become mainstream and represent a major advance in weight management by regulating appetite and improving metabolic health to produce meaningful weight loss for millions. Ads reflect growing acceptance but do not show how to sustain results long term. Lasting weight health requires more than medication: daily lifestyle choices, consistent support, and ongoing work sustain progress after initial motivation wanes. Millions already use GLP-1s and demand is rising, shifting focus from access to achieving durable outcomes. An ecosystem of clinical care, behavioral support, and programmatic resources is essential to help people live on these therapies and maintain health.
Read at Fortune
Unable to calculate read time
[
|
]